Cineverse (NASDAQ:CNVS) Bolsa

Cineverse

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Cineverse Corp

Outlook
For fiscal 2025, the Company tightens its revenue guidance to £660m to £670m and expects to be at the higher end of this range. The Company also raises its Adjusted EBITDA guidance to between £180 million and £190 million. The club remains committed to, and in compliance with, both the Premier League's Profit and Sustainability Rules and UEFA's Financial Fair Play Regulations.

Earnings

News

Guidance

General

MANU

Manchester United Tightens Its 2025 Revenue Guidance From £650M-£670M To £660M-£670M And Expects To Be At The Higher End Of This Range; Raises Its Adjusted EBITDA Guidance To Between £180M-£190M Up From Prior Guidance Of £145M-£160M

Needham analyst Laura Martin reiterates Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Buy and maintains $84 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Trade Desk, Maintains $84 Price Target

LULU: -23% &#x7C; <a href="https://www.benzinga.com//node/45803006">Lululemon Athletica shares are trading lower after the company cut its FY25 GAAP EPS guidance below estimates.</a>
&nbsp;
AVGO: -5% &#x7C; <a href="https://www.benzinga.com//node/45802886">Broadcom shares are trading lower following Q2 reported financial results.</a>
&nbsp;
TSLA: 6% &#x7C; <a href="https://www.benzinga.com//node/45807968">Trump Signals Truce With Elon Musk After Online Feud: 'It's Going Very Well, Never Done Better'</a>

Movers

Trading Ideas

AVGO

LULU

TSLA

Market-Moving News for June 6th

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) with a Buy and maintains $6 price target.

ARTL

D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $6 Price Target

Needham analyst Ryan Koontz reiterates Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Buy and maintains $90 price target.

CIEN

Needham Reiterates Buy on Ciena, Maintains $90 Price Target

Phosphate and Potash Operations Outlook
Phosphate sales volumes for the second quarter of 2025 are expected to be 1.5-1.6 million tonnes, revised down from 1.7-1.9 million tonnes. 2025 full year production volume is now expected to be 7.0-7.3 million tonnes, revised down from 7.2-7.6 million tonnes.

UPDATE: Mosaic Company Revises Outlook: Sees Q2 Phosphate Sales Volume At 1.5–1.6M Tonnes, Down From 1.7M–1.9M Prior; FY25 Output Trimmed To 7.0M–7.3M Tonnes Vs 7.2M-7.6M Tonnes Prior

RYVYL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, announced the securityholder of its remaining 8% Senior Convertible Note ("Note"), has converted the entire outstanding principal balance of $4.0 million and accrued interest of $136,000 into 7.1 million shares of common stock.

RVYL

RYVYL's Securityholder Converts Final $4M Senior Note, Including $136K Interest, Into 7.1M Shares

Manchester United Q3 2025 Adj. EPS $(0.04) May Not Be Comparable To $(0.33) Estimate, Sales $207.26M Beat $202.47M Estimate

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Constellation Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>)</h3>
<ul class="wp-block-list">
<li>On June 2, Constellation Brands announced delivery of notices of redemption for 4.75% senior notes due 2025 and 5.00% senior notes due 2026. The company's stock fell around 9% over the past month and has a 52-week low of $160.46.</li>
<li>RSI Value: 26.8</li>
<li>STZ Price Action: Shares of Constellation fell 3.6% to close at $170.60 on Thursday.</li>
<li>Edge Stock Ratings: 18.63 Momentum score with Value at 14.10. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/STZ"><img loading="lazy" decoding="async" width="441" height="183" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87.png" alt="" class="wp-image-941078" style="width:325px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87-300x124.png 300w" sizes="(max-width: 441px) 100vw, 441px" /></a></figure>
<h3 class="wp-block-heading">Coca-Cola Consolidated Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>)</h3>
<ul class="wp-block-list">
<li>On May 15, Coca-Cola Consolidated announced a $90 million investment in Columbus facility. &#8220;The investment we&#8217;ve made here in Columbus is evidence of our focus on growth in Columbus,&#8221; said Sam Meiner, VP, Mid-West Market Unit at Coca-Cola Consolidated. &#8220;This commitment to our teammates and production capabilities is a long-term dedication to improving how we serve the world&#8217;s best brands and flavors to our communities and the people of Ohio.&#8221; The company's stock fell around 10% over the past month and <a href="https://www.benzinga.com/quote/COKE">has a 52-week low</a> of $96.60.</li>
<li>RSI Value: 25.8</li>
<li>COKE Price Action: Shares of Coca-Cola Consolidated fell 1.4% to close at $106.17 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606">COKE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606"><img loading="lazy" decoding="async" width="927" height="851" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88.png" alt="" class="wp-image-941079" style="width:652px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88-768x705.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Diageo PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>)</h3>
<ul class="wp-block-list">
<li>On May 19, Diageo reported a third-quarter fiscal 2025 trading update that showed steady growth in organic net sales and progress on its operational transformation efforts. The maker of Smirnoff and Guinness posted $4.4 billion in net sales for the quarter ended March 31, marking a 2.9% increase year-over-year. Organic net sales rose 5.9%, driven by stronger pricing and shipment volumes. The company's stock fell around 8% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/DEO">low of $100.72.</a></li>
<li>RSI Value: 29</li>
<li>DEO Ltd Price Action: Shares of Diageo fell 5.1% to close at $105.20 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606">DEO shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606"><img loading="lazy" decoding="async" width="862" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89.png" alt="" class="wp-image-941080" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89.png 862w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89-300x290.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89-768x741.png 768w" sizes="(max-width: 862px) 100vw, 862px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45789751/jim-cramer-likes-dominion-energy-but-isnt-a-fan-of-this-real-estate-stock">Jim Cramer Likes Dominion Energy, But Isn&#8217;t &#8216;A Fan&#8217; Of This Real Estate Stock</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

COKE

Top 3 Risk Off Stocks That Could Blast Off This Month

Needham analyst Mike Cikos reiterates Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) with a Buy and maintains $24 price target.

CLBT

Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target

Fury Gold Mines Limited (NYSE:<a href="https://www.benzinga.com/stock/FURY#NYSE">FURY</a>) ("Fury" or the "Company") announces that the proposed private placement offering announced June 5, 2025 has been increased from C$2,500,000 to C$3,080,000. Fury now intends to privately place with a small group of accredited and institutional investors in Canada a total of 4,000,000 flow-through common shares (the "Shares") of the Company, at a price of C$0.77 per Share for total gross proceeds of C$3,080,000 (the "Offering"). This offering figure could increase by up to approximately 15.4% if a strategic investor elects to exercise its pre-emptive participation rights disclosed in a <a href="https://www.globenewswire.com/Tracker?data=HQaYc8Cgq_iu2dRsUPGUu4P8s3eHB2eh9WbW-ZLoEWjXoCqjvRLyTfYk3hp6kqzAmBb84_tbBVoR_n5MFK0Ixq9Z6MdXWXYjmhnHy6AtbvrgY_wLYJ1ItwqiqvhkOwikomCI1oUBmQMZQ53iXZrkOtyfCPzsDPY_b__Zik8XVFI=">May 27, 2025 news release</a>.
The Offering is expected to close on or about June 19, 2025 (the "Closing Date"), subject to execution of subscription agreements and customary closing conditions, including receipt of all necessary approvals, including the approval of the Toronto Stock Exchange ("TSX") and the NYSE American LLC. Other previously announced terms and conditions remain the same.

FURY

Fury Gold Mines Increases Proposed Private Placement Offering From C$2.50M To C$3.08M

G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is looking for Q2 Adj EPS of $0.02-$0.12 vs $0.48 analyst estimate. Q2 Revenue expected to be more than $570.00M vs $621.00M Est

GIII

G-III Apparel Group Sees Q2 EPS $0.02-$0.12; Q2  Revenue Expected To Be Approximately $570.00M vs $621.00M Est

PRPH

ProPhase Labs Forms Clinical Science Advisory Board To Support Clinical Adoption And Commercialization Of Breakthrough BE-Smart Molecular Test For Esophageal Disease

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) with a Buy and maintains $19 price target.

RCEL

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $19 Price Target

Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) (the "Company" or "Sandisk") announced today the pricing of a secondary public offering (the "Offering") of 18,534,581 shares of its common stock (the "SNDK Shares") currently owned by Western Digital Corporation, the Company's former parent ("WDC"). The size of the offering reflects an increase from the 17,000,000 shares of common stock originally proposed to be sold. The SNDK Shares will be offered at a public offering price of $38.50 per share. Sandisk is not selling any shares of common stock and will not receive any proceeds from the sale of the SNDK Shares in the Offering or from the debt-for-equity exchange.

SNDK

Sandisk Announces Pricing For Expanded Secondary Offering; WDC to Sell 18.5M Shares, Priced at $38.50/Shr

Needham analyst Tom Nikic maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Buy and lowers the price target from $366 to $317.

Needham Maintains Buy on Lululemon Athletica, Lowers Price Target to $317

Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 87.88 percent. This is a 87.1 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $202.03 million which missed the analyst consensus estimate of $202.47 million by 0.22 percent. This is a 16.53 percent increase over sales of $173.37 million the same period last year.

Earnings Beats

Earnings Misses

Manchester United Q3 Adj. EPS $(0.04) Beats $(0.33) Estimate, Sales $202.03M Miss $202.47M Estimate

G-III Apparel Anticipates Unmitigated Cost Of Tariffs On Goods Imported Into The United States Will Result In Additional Expense Of $135M, Which Will Primarily Be Weighted To The Second Half Of The Year

<a href="https://www.globenewswire.com/Tracker?data=n4VAc1wDtm5Gx7yfSA9G9Bdm2S_5VbQKkJDwPg3B940asDE5ZukU5_AOibtKC3kemI6XkVzqXtwCjRwSJvfq1cpQeANnCCU7jEhQPnli8rQ=">BioCryst Pharmaceuticals, Inc. </a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO&#xAE; (berotralstat) has been approved for the routine prevention of hereditary angioedema (HAE) attacks in patients aged 12 years and older. This reimbursement approval in the Netherlands marks national reimbursement for ORLADEYO across all major European countries, providing HAE patients with access to the first oral, once-daily preventive therapy.

BCRX

Netherlands Approves BioCryst Pharma's ORLADEYO For Hereditary Angioedema Prevention, Expanding National Access Across Europe

G-III Apparel Has Withdrawn Its Net Income, Non-GAAP Net Income And Adjusted EBITDA Guidance For FY26 Due To Uncertainty Around Tariffs And Related Macroeconomic Conditions

Entertainment

Press Releases

Cineverse Acquires U.S. Rights to Lynchian Thriller The Things You Kill; Fall Theatrical Release Planned

Cineverse Launches "Land of the Lost" and "So…Real" FAST Channels on Philo

Cineverse Announces Start of Production for Holiday Horror Film, Silent Night, Deadly Night

Cineverse Promotes John Squires and Megan Vavarro to Co-Managing Directors of Leading Horror Brand, Bloody Disgusting

/C O R R E C T I O N -- Cineverse Corp./

Cineverse Acquires U.S. Rights for Return to Silent Hill, The Newest Installment in the popular Video Game Horror Film Franchise from Davis Films

Cineverse Launches Dedicated Motion Pictures Group to Take Advantage of High-Growth Feature Film Business Opportunity

Cineverse Accelerates Technology Monetization, Launches Technology Group to Drive AI Innovation and Rapid Commercial Expansion

Cineverse Motion Pictures Group's Escape From The 21st Century Hits Theaters on June 9, Tickets on Sale Now for The Bold, Genre-blending Time-Travel Adventure

Cineverse's Dog Whisperer and Bob Ross FAST Channels Expand into Australia with Samsung TV Plus Australia Launch

CNVS

Anghami

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

CuriosityStream Inc. - Class A Common Stock

CuriosityStream

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Eventbrite

Gaia

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares (each representing ten (10) Class A Ordinary Shares)

Comments

Cineverse

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL